Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Nature Communications|September 7, 2017
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a timeShumei Chia, Joo-Leng Low, Xiaoqian Zhang, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.Cell|September 25, 2020
Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular CarcinomaAnkur Sharma, Justine Jia Wen Seow, Charles-Antoine Dutertre, et al.The Lancet. Oncology|January 18, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trialWan-Qin Chong, Jia-Li Low, Joshua K Tay, et al.Nature Communications|February 10, 2025
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneitySiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.Gut|July 22, 2025
Targeting Treg-fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinomaAldo Prawira, Hang Xu, Yu Mei, et al.Cancer Discovery|June 17, 2024
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal CancersRaghuvaran Shanmugam, Prativa Majee, Wei Shi, et al.Nature Reviews. Gastroenterology & Hepatology|October 13, 2025
Towards a reference cell atlas of liver diversity over the human lifespanSarah A Taylor, Gary D Bader, Sonya MacParland, et al.Nature Cancer|June 6, 2024
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistanceTommaso Scolaro, Marta Manco, Mathieu Pecqueux, et al.JCI Insight|February 25, 2025
Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinomaShi Yong Neo, Timothy Wai Ho Shuen, Shruti Khare, et al.Pageof 9